Highest-materiality recent filing
WTW Q1 2026: revenue $2.4B (+8% YoY), adj. diluted EPS $3.72 (+19%), organic growth 3%
Revenue $2.412B (+8% YoY); organic growth 3%; diluted EPS $3.10 (+33%).
WTW Q4 adj. EPS $8.12 (+2%), organic rev +6%; FY adj. EPS $17.08 (+5%)
Q4 revenue $2.94B (organic +6%); adj. EPS $8.12 (+2%); operating margin 34.6%.
WTW completes acquisition of Newfront; expands U.S. middle market & tech capabilities
Completed acquisition of Newfront, a top-40 U.S. broker specializing in tech, fintech, and life sciences.
WTW enters $775M delayed draw term loan to finance Newfront acquisition
Delayed draw term loan facility of $775M, unsecured, matures 3 years from initial draw or 3 years after 2 months post-acquisition.
Willis Towers Watson issues $1B in senior notes to fund Newfront acquisition & refinance debt
Issued $700M 4.550% notes due 2031 and $300M 5.150% notes due 2036; net proceeds ~$990M.
WTW to acquire Newfront for $1.3B to expand U.S. middle-market and tech capabilities
Upfront payment of $1.05B ($900M cash + $150M equity) plus up to $250M contingent consideration; total $1.3B.
WTW reports Q3 2025 adjusted EPS $3.07 (+11% YoY); organic revenue growth 5%
Revenue $2.29B flat YoY (organic +5%); diluted EPS $3.11 vs loss $16.44 prior year.
WTW Q3 adj EPS $3.07 (+11% YoY); organic revenue +5%; margins expand 230 bps
Revenue $2.29B flat YoY as TRANZACT sale offset; organic revenue grew 5%.
WTW Q2 2025: Adj. EPS $2.86 (+20% YoY), organic revenue +5%, margins expand
Revenue $2.26B flat (organic +5%); Diluted EPS $3.32 (+144%), Adjusted EPS $2.86 (+20%).
WTW Q4 adjusted EPS $8.13 (+9%); FY adjusted EPS $16.93 (+17%); revenue up 5% organic
Q4 revenue $3.04B (+4% reported, +5% organic); FY revenue $9.93B (+5% reported and organic).
WTW completes sale of TRANZACT to GTCR and Recognize
Sale closed on Dec 31, 2024; announced Jan 2, 2025.
WTW Q3 adj. EPS $2.93 beats; revenue up 6% organic; FY24 guidance reaffirmed
Revenue $2.29B, up 6% YoY (organic 6%); segments: HWC +4%, R&B +10%.
WTW to sell TRANZACT for $632.4M; expects Q3 impairment charges of $1.6–$2.1B
Sale to GTCR and Recognize at $632.4M subject to adjustments; expected close by end of 2024.
WTW Q2 revenue $2.27B (+5%), adj. EPS $2.55 (+24%); raises 2024 outlook low end
Revenue $2.27B, reported +5%, organic +6%; diluted EPS $1.36 (+55%), adjusted diluted EPS $2.55 (+24%).
WTW Q1 revenue up 4% to $2.34B; adj. EPS $3.29 beats prior year; guidance reaffirmed
Q1 revenue $2.34B (+4% reported, +5% organic); diluted EPS $1.83 (down 3%); adjusted diluted EPS $3.29 (+16% YoY).
The Board has selected Paul Reilly, an independent director of the Board, to become the Non-Executive Chair of the Board effective as of the conclusion of the 2025 AGM, subject to his re-election.
Paul Thomas, the current Non-Executive Chair of the Board of Directors (the “Board”) of Willis Towers Watson Public Limited Company (the “Company”), informed the Board that he intends to retire at the end of his current term and will not stand for reelection at the Company’s 2025 Annual Meeting of Stockholders (“AGM”).
Max materiality 0.85 · Median 0.68 · Most common event earnings